Articles
Commissions we earn from partner links on this page do not affect our opinions or evaluations. For the millions of people worldwide affected by androgenic alopecia (AGA), a condition causing progressive hair thinning, finasteride represents a scientifically proven treatment. As hair loss treatments continue to evolve, low-dose topical finasteride has emerged as an effective option…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Pattern hair loss (androgenic alopecia) is increasingly prevalent with age, affecting many adult men and women. Topical finasteride is one of the most proven treatments available. However, choosing the right provider can be challenging in today’s saturated market, which…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Millions of people globally experience some form of hair loss, which typically increases with age. Pattern baldness, also known as androgenic alopecia (AGA), is the leading type, affecting more than half of men over 50 and a significant portion…
Nektar Therapeutics has announced topline results from its Phase 2b REZOLVE-AA trial evaluating rezpegaldesleukin (REZPEG) in patients with severe-to-very-severe alopecia areata (AA). The data establish clinical proof of concept and support advancement into Phase 3 development, positioning rezpegaldesleukin as a potential non-JAK option for this autoimmune hair-loss condition. What is Rezpegaldesleukin? Rezpegaldesleukin is a first-in-class…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Minoxidil is a clinically proven hair-regrowth agent that is one of only two FDA-approved treatments for pattern hair loss. It has consistently yielded favorable outcomes for millions of men worldwide, and its effectiveness is supported by decades of study…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Today’s market is saturated with hair-loss products for women, and navigating advertising claims to find effective treatments can be challenging. Top products demonstrate proven efficacy and safety with customization features and affordability to suit a range of female hair-restoration…
Absci has announced that the first volunteers have now been dosed in its Phase 1/2a HEADLINE trial evaluating ABS-201, a novel anti-prolactin receptor (PRLR) antibody designed with the company’s generative AI platform. What is Absci? Absci is a biotech company focused on using generative AI and synthetic biology to design next-generation biologics. Their pitch is…
Cosmo Pharmaceuticals has announced impressive topline results from its two pivotal Phase 3 trials evaluating clascoterone 5% topical solution for male androgenic alopecia (AGA). These data mark what may be the first major therapeutic breakthrough for male-pattern hair loss in over 30 years. What is Clascoterone? Clascoterone is a topical androgen receptor inhibitor designed to…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Oral finasteride remains one of the most proven treatments for male pattern hair loss, backed by decades of data showing steady improvement in hair density and prevention of further thinning. However, dramatic transformation photos online can create unrealistic expectations.…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Millions of individuals worldwide are estimated to suffer from androgenetic alopecia, which becomes increasingly common with age. Among popular DHT-blocking treatments, topical dutasteride is considered the most potent, providing dual enzyme inhibition for superior effectiveness compared to finasteride. The…